Evidence map›Paper›PMID 30090366›Full record

ArticleToxicology research2016

Mycotoxin ochratoxin A disrupts renal development

Ting-Shuan Wu, Jiann-Jou Yang, Yan-Wei Wang, Feng-Yih Yu, Biing-Hui Liu

Open access · bronzeAbstract read
In one paragraph

Article in Toxicology research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Fumonisin BTropical life sciences research · 2020
    Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Ting-Shuan WuGraduate Institute of Toxicology , College of Medicine , National Taiwan University , Taipei , Taiwan . Email: biingliu@ntu.edu.tw ; ; Tel: +886-2-23123456, ext 88602.
Jiann-Jou YangDepartment of Biomedical Sciences , Chung Shan Medical University , Taiwan . Email: fengyu@csmu.edu.tw.
Yan-Wei WangDepartment of Biomedical Sciences , Chung Shan Medical University , Taiwan . Email: fengyu@csmu.edu.tw.
Feng-Yih YuDepartment of Biomedical Sciences , Chung Shan Medical University , Taiwan . Email: fengyu@csmu.edu.tw.
Biing-Hui LiuGraduate Institute of Toxicology , College of Medicine , National Taiwan University , Taipei , Taiwan . Email: biingliu@ntu.edu.tw ; ; Tel: +886-2-23123456, ext 88602.
Chung Shan Medical University · TWInstitute of Pharmacology · CZChung Shan Medical University Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mycotoxin ochratoxin A (OTA) frequently contaminates various food and feed products, including cereals, coffee and wine. While the nephrotoxicity and teratogenicity of OTA have been extensively documented, the molecular mechanisms associated with OTA toxicity remained poorly understood in a developing organism. We showed that zebrafish embryos exposed to OTA demonstrated incorrect heart looping and small heart chambers. OTA also impaired the renal morphology and reduced the glomerular filtration rate of the embryonic zebrafish. The treatment of embryos with OTA attenuated the expression of the prolactin receptor, a gene (PRLRa) that has a key role in organogenesis and osmoregulation in vertebrates. OTA not only inhibited the phosphorylation of STAT5 and AKT, but also down-regulated the level of serpina1 mRNA in a dose-dependent manner. On the other hand, the microRNA profiling based on RNA sequencing revealed the up-regulation of microRNA-731 (miR-731) in the OTA-treated embryos. Further

Identifiers

PMID30090366
PMCPMC6062247
OpenAlexW2231838341

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.